These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11028837)

  • 21. Ondansetron and pruritus in chronic liver disease: a controlled study.
    Jones EA; Molenaar HA; Oosting J
    Hepatogastroenterology; 2007 Jun; 54(76):1196-9. PubMed ID: 17629069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness.
    Levine ME; Chillas JC; Stern RM; Knox GW
    Aviat Space Environ Med; 2000 Nov; 71(11):1111-4. PubMed ID: 11086664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrocardiographic findings after 5-HT3 receptor antagonists and chemotherapy in children with cancer.
    Pinarli FG; Elli M; Dagdemir A; Baysal K; Acar S
    Pediatr Blood Cancer; 2006 Oct; 47(5):567-71. PubMed ID: 16317736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
    ; Wong RK; Paul N; Ding K; Whitehead M; Brundage M; Fyles A; Wilke D; Nabid A; Fortin A; Wilson D; McKenzie M; Ackerman I; Souhami L; Chabot P; Pater J
    J Clin Oncol; 2006 Jul; 24(21):3458-64. PubMed ID: 16849762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence.
    Johnson BA; Roache JD; Ait-Daoud N; Javors MA; Harrison JM; Elkashef A; Mojsiak J; Li SH; Bloch DA
    Drug Alcohol Depend; 2006 Oct; 84(3):256-63. PubMed ID: 16631323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome.
    Weatherley-Jones E; Nicholl JP; Thomas KJ; Parry GJ; McKendrick MW; Green ST; Stanley PJ; Lynch SP
    J Psychosom Res; 2004 Feb; 56(2):189-97. PubMed ID: 15016577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
    Blockmans D; Persoons P; Van Houdenhove B; Bobbaers H
    Am J Med; 2006 Feb; 119(2):167.e23-30. PubMed ID: 16443425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinguishing patients with chronic fatigue from those with chronic fatigue syndrome: a diagnostic study in UK primary care.
    Darbishire L; Ridsdale L; Seed PT
    Br J Gen Pract; 2003 Jun; 53(491):441-5. PubMed ID: 12939888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ondansetron reduces the craving of biologically predisposed alcoholics.
    Johnson BA; Roache JD; Ait-Daoud N; Zanca NA; Velazquez M
    Psychopharmacology (Berl); 2002 Apr; 160(4):408-13. PubMed ID: 11919668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonist tropisetron.
    Müller W; Stratz T
    Scand J Rheumatol Suppl; 2004; 119():44-8. PubMed ID: 15515413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of generalized tendomyopathy (fibromyalgia) caused by blocking 5-HT3 receptors].
    Stratz T; Schochat T; Hrycaj P; Lacki J; Mennet P; Färber L; Schweiger C; Müller W
    Z Rheumatol; 1994; 53(6):335-8. PubMed ID: 7871905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulatory function of the 5-HT3 receptor antagonist tropisetron.
    Schneider EM; Ma X; Stratz T; Müller W; Lorenz I; Seeling WD
    Scand J Rheumatol Suppl; 2004; 119():34-40. PubMed ID: 15515411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
    Jones E; Koyama T; Ho RH; Kuttesch J; Shankar S; Whitlock JA; Cartwright J; Frangoul H
    Pediatr Blood Cancer; 2007 Mar; 48(3):330-2. PubMed ID: 16304666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5-HT3 receptor antagonist-mediated improvement in fatigue-like behaviour in cholestatic rats.
    Nguyen H; Wang H; le T; Ho W; Sharkey KA; Swain MG
    Neurogastroenterol Motil; 2008 Mar; 20(3):228-35. PubMed ID: 17919312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective, open-label trial of ondansetron in adolescents with alcohol dependence.
    Dawes MA; Johnson BA; Ait-Daoud N; Ma JZ; Cornelius JR
    Addict Behav; 2005 Jul; 30(6):1077-85. PubMed ID: 15925118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do cytochrome enzymes influence the therapeutic effect of tropisetron in fibromyalgia?
    Stratz T; Kees F; Müller W
    Drugs Exp Clin Res; 2003; 29(2):91-4. PubMed ID: 12951840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Postoperative vomiting].
    Vimláti L; Pallós J; Nagy K; Murányi M; Szabó Z; Karoliny V; Steiber J
    Orv Hetil; 2002 Apr; 143(16):819-24. PubMed ID: 12053882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ondansetron and tropisetron do not prevent intraspinal morphine- and fentanyl-induced pruritus in elective cesarean delivery.
    Sarvela PJ; Halonen PM; Soikkeli AI; Kainu JP; Korttila KT
    Acta Anaesthesiol Scand; 2006 Feb; 50(2):239-44. PubMed ID: 16430549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting.
    Rosow CE; Haspel KL; Smith SE; Grecu L; Bittner EA
    Anesth Analg; 2008 May; 106(5):1407-9, table of contents. PubMed ID: 18420852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.